Literature DB >> 14720578

TGF-beta, T-cell tolerance and anti-CD3 therapy.

Ramireddy Bommireddy1, Thomas Doetschman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14720578      PMCID： PMC2796480          DOI： 10.1016/j.molmed.2003.11.007

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN： 1471-4914            Impact factor:   11.951


× No keyword cloud information.
  51 in total

Review 1.  Signal transduction by the TCR for antigen.

Authors:  L P Kane; J Lin; A Weiss
Journal:  Curr Opin Immunol       Date:  2000-06       Impact factor: 7.486

2.  Anti-CD3 epsilon F(ab')2 prevents graft-versus-host disease by selectively depleting donor T cells activated by recipient alloantigens.

Authors:  X Z Yu; S J Bidwell; P J Martin; C Anasetti
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

3.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.

Authors:  B Salomon; D J Lenschow; L Rhee; N Ashourian; B Singh; A Sharpe; J A Bluestone
Journal:  Immunity       Date:  2000-04       Impact factor: 31.745

4.  Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction.

Authors:  Wilma L Suarez-Pinzon; Yvonne Marcoux; Aziz Ghahary; Alex Rabinovitch
Journal:  Cell Transplant       Date:  2002       Impact factor: 4.064

5.  Cutting edge: anti-CD154 therapeutic antibodies induce infectious transplantation tolerance.

Authors:  L Graca; K Honey; E Adams; S P Cobbold; H Waldmann
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

6.  Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation.

Authors:  M Demetriou; M Granovsky; S Quaggin; J W Dennis
Journal:  Nature       Date:  2001-02-08       Impact factor: 49.962

7.  Transforming growth factor-beta induces apoptosis in activated murine T cells through the activation of caspase 1-like protease.

Authors:  E J Chung; S H Choi; Y H Shim; Y J Bang; K C Hur; C W Kim
Journal:  Cell Immunol       Date:  2000-08-25       Impact factor: 4.868

8.  Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3gamma1(Ala-Ala).

Authors:  Kevan C Herold; Joshua B Burton; Fleur Francois; Ena Poumian-Ruiz; Mariela Glandt; Jeffrey A Bluestone
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

9.  Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor.

Authors:  P J Lucas; S J Kim; S J Melby; R E Gress
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

10.  CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms.

Authors:  Kevin J Maloy; Laurence Salaun; Rachel Cahill; Gordon Dougan; Nigel J Saunders; Fiona Powrie
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307
View more
  6 in total

1.  Elimination of both CD4+ and CD8+ T cells but not B cells eliminates inflammation and prolongs the survival of TGFbeta1-deficient mice.

Authors:  Ramireddy Bommireddy; Sandra J Engle; Ilona Ormsby; Gregory P Boivin; George F Babcock; Thomas Doetschman
Journal:  Cell Immunol       Date:  2005-03-29       Impact factor: 4.868

2.  The Critical Role of TGF-beta1 in the Development of Induced Foxp3+ Regulatory T Cells.

Authors:  Song Guo Zheng
Journal:  Int J Clin Exp Med       Date:  2008-06-10

Review 3.  TGFbeta1 and Treg cells: alliance for tolerance.

Authors:  Ramireddy Bommireddy; Thomas Doetschman
Journal:  Trends Mol Med       Date:  2007-10-30       Impact factor: 11.951

4.  TGFbeta1 deficiency does not affect the generation and maintenance of CD4+CD25+FOXP3+ putative Treg cells, but causes their numerical inadequacy and loss of regulatory function.

Authors:  Ramireddy Bommireddy; George F Babcock; Ram R Singh; Thomas Doetschman
Journal:  Clin Immunol       Date:  2008-03-04       Impact factor: 3.969

Review 5.  Implications of immune dysfunction on endometriosis associated infertility.

Authors:  Jessica E Miller; Soo Hyun Ahn; Stephany P Monsanto; Kasra Khalaj; Madhuri Koti; Chandrakant Tayade
Journal:  Oncotarget       Date:  2017-01-24

Review 6.  The Role of HBZ in HTLV-1-Induced Oncogenesis.

Authors:  Tiejun Zhao
Journal:  Viruses       Date:  2016-02-02       Impact factor: 5.048
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.